INDIGO Trial Understanding IDH Mutations in Grade 2 Gliomas: Role and Significance Explored Brain 3 Mins Read6 Dr. Katherine Peters from Duke University Medical Center discussed the current treatments and their limitations for low-grade glioma patients with…
